Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Firefly Neuroscience (AIFF) Return on Sales (2016 - 2025)

Historic Return on Sales for Firefly Neuroscience (AIFF) over the last 15 years, with Q3 2025 value amounting to 6.8%.

  • Firefly Neuroscience's Return on Sales rose 1231700.0% to 6.8% in Q3 2025 from the same period last year, while for Sep 2025 it was 31.39%, marking a year-over-year increase of 265700.0%. This contributed to the annual value of 0.67% for FY2023, which is 3600.0% up from last year.
  • Latest data reveals that Firefly Neuroscience reported Return on Sales of 6.8% as of Q3 2025, which was up 1231700.0% from 6.13% recorded in Q2 2025.
  • Firefly Neuroscience's 5-year Return on Sales high stood at 68.82% for Q4 2024, and its period low was 300.7% during Q1 2025.
  • Its 5-year average for Return on Sales is 22.59%, with a median of 0.52% in 2021.
  • Its Return on Sales has fluctuated over the past 5 years, first crashed by -1285600bps in 2024, then skyrocketed by 1231700bps in 2025.
  • Over the past 5 years, Firefly Neuroscience's Return on Sales (Quarter) stood at 0.52% in 2021, then plummeted by -715bps to 4.26% in 2022, then surged by 98bps to 0.08% in 2023, then skyrocketed by 86672bps to 68.82% in 2024, then plummeted by -110bps to 6.8% in 2025.
  • Its Return on Sales stands at 6.8% for Q3 2025, versus 6.13% for Q2 2025 and 300.7% for Q1 2025.